Peripheral Vascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Peripheral Vascular Disease stocks.

Peripheral Vascular Disease Stocks Recent News

Date Stock Title
Nov 20 LNTH Why Lantheus Holdings Stock Won Big on Wednesday
Nov 20 BSX Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio
Nov 20 MMSI Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
Nov 20 LNTH Lantheus Holdings launches $250M share buyback program
Nov 20 LNTH Lantheus Announces Share Repurchase Program
Nov 19 ANGO NVRO Stock Declines Despite Positive Study Data of Nevro1 System
Nov 19 BSX Reasons to Retain BSX Stock in Your Portfolio for Now
Nov 19 BSX BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
Nov 19 BSX Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Nov 18 MMSI How Is The Market Feeling About Merit Medical Systems?
Nov 18 BSX Boston Sci stock climbs 5% on positive Watchman FLX data
Nov 18 ANGO INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
Nov 18 BSX Inside a $400 billion bet on the brain-computer interface revolution
Nov 18 BSX Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today
Nov 18 BSX Boston Scientific’s Watchman could be new option for patients post ablation: study
Nov 18 BSX The PFA race is heating up. Here’s where the market stands after J&J’s approval.
Nov 18 BSX Boston Scientific reports outcomes from trial of LAAC device
Nov 16 BSX Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
Nov 15 BSX Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)
Nov 15 BSX Boston Scientific closes acquisition of Axonics
Peripheral Vascular Disease

Peripheral artery disease (PAD) is an abnormal narrowing of arteries other than those that supply the heart or brain. When narrowing occurs in the heart, it is called coronary artery disease, and in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms include skin ulcers, bluish skin, cold skin, or abnormal nail and hair growth in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke. Up to 50% of people with PAD do not have symptoms.The greatest risk factor for PAD is cigarette smoking. Other risk factors include diabetes, high blood pressure, kidney problems, and high blood cholesterol. The most common underlying mechanism of peripheral artery disease is atherosclerosis, especially in individuals over 40 years old. Other mechanisms include artery spasm, blood clots, trauma, fibromuscular dysplasia, and vasculitis. PAD is typically diagnosed by finding an ankle-brachial index (ABI) less than 0.90, which is the systolic blood pressure at the ankle divided by the systolic blood pressure of the arm. Duplex ultrasonography and angiography may also be used. Angiography is more accurate and allows for treatment at the same time; however, it is associated with greater risks.It is unclear if screening for peripheral artery disease in people without symptoms is useful as it has not been properly studied. In those with intermittent claudication from PAD, stopping smoking and supervised exercise therapy improve outcomes. Medications, including statins, ACE inhibitors, and cilostazol may also help. Aspirin does not appear to help those with mild disease but is usually recommended in those with more significant disease due to the increased risk of heart attacks. Anticoagulants such as warfarin are not typically of benefit. Procedures used to treat the disease include bypass grafting, angioplasty, and atherectomy.In 2015, about 155 million people had PAD worldwide. It becomes more common with age. In the developed world, it affects about 5.3% of 45- to 50-year-olds and 18.6% of 85- to 90-year-olds. In the developing world, it affects 4.6% of people between the ages of 45 and 50 and 15% of people between the ages of 85 and 90. PAD in the developed world is equally common among men and women, though in the developing world, women are more commonly affected. In 2015 PAD resulted in about 52,500 deaths, which is an increase from the 16,000 deaths in 1990.

Browse All Tags